Tissue-engineered bone biomimetic to regenerate calvarial critical- sized defects in athymic rats

Journal of Biomedical Materials Research

Volumn 45, Issue 4, 1999, Pages 414-421

  Winn, Shelley R ^a   Schmitt, John M ^a   Buck, David ^a   Hu, Yunhua ^a   Grainger, David ^b   Hollinger, Jeffrey O ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b GAMMA A Technologies Inc   (United States)

Author keywords

Bone regeneration; Osteoprecursor cell; Poly(D,L lactide); Recombinant human bone morphogenetic protein 2

Indexed keywords

BIOMEDICAL EQUIPMENT; BIOPOLYMERS; CELLS; NUMERICAL METHODS; PROTEINS;

BONE REGENERATION; CALVARIAL CRITICAL SIZED DEFECTS; OSTEOPRECURSOR CELL; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2;

BONE;

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; LACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMEDICAL ENGINEERING; BONE REGENERATION; CALVARIA; DATA ANALYSIS; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OUTCOMES RESEARCH; RAT; STEM CELL;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE SUBSTITUTES; COLLAGEN; HUMANS; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; OSTEOBLASTS; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, NUDE; RECOMBINANT PROTEINS; SKULL; SURFACE PROPERTIES;

EID: 0033564001     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19990615)45:4<414::AID-JBM17>3.0.CO;2-Z     Document Type: Article

References (45)

1. Gruss J, Antonyshyn O, Phillips J. Early definitive bone and soft-tissue reconstruction of major gunshot wounds of the face. Plast Reconstr Surg 1991,87:436-450.
2. Marx RE. Current advances in reconstruction of the mandible in head and neck cancer surgery. Semin Surg Oncol 1991;7:47-57.
3. Nguyen PN, Sullivan PK. Issues and controversies in the management of cleft palate. Clin Plast Surg 1993;20:671-682.
4. Reddi AH. Bone and cartilage differentiation. Curr Opin Genet Dev 1994;4:737.
5. Rosen V, Thies S. The BMP proteins in bone formation and repair. Trends Genet 1992;8:97-102.
6. Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reproduct Dev 1992;32:160-167.
7. Hollinger JO, Buck DC, Bruder S. Biology of bone healing: Its impact on clinical therapy. In: Lynch S, editor. Tissue engineering in dentistry. San Diego, CA: Quintessence. To appear.
8. Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Alder M, Nummikoski P. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus augmentation. Int J Periodont Restor Dent 1997;17:11-25.
9. Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M, Lilly L, Cochran D. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation of augmentation. Int J Periodont Restor Dent 1997;17:125-139.
10. Kadiyala S, Kraus KH, Bruder SP. Canine mesenchymal stem cell-based therapy for the regeneration of bone. Trans Tissue Eng Soc 1996;20.
11. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 1998;16:155-162.
12. Kadiyala S, Jaiswal N, Bruder SP. Culture-expanded, bone marrow-derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect. Tiss Engineer 1997;3:173-185.
13. Winn SR, Randolph G, Uludag H, Wong S, Hollinger JO. Establishing an immortalized human osteoprecursor cell line. J Bone Mineral Res. To appear.
14. Sampath TK, Rueger DC. Structure, function, and orthopedic applications of osteogenic protein-1(OP-1). Compl Orthopaed (Winter) 1994;101.
15. Lane JM, Tomin A, Bostrom M, Rosen V, Wozney JM. Orthopedic application of BMP-2 in fracture healing. First Int Conf Bone Morph Prot 1993;23.
16. Brekke J. A rationale for delivery of osteoinductive proteins. Tiss Engineer 1996;2:97-114.
17. Hollinger JO, Leong K. Poly(alpha-hydroxy acids): Carriers for bone morphogenetic proteins. Biomaterials 1996;17:187-194.
18. Hollinger JO, editor. Biomedical applications of synthetic biodegradable polymers. Boca Raton: CRC Press; 1995.
19. Ishaug SL, Yaszemski MJ, Bizios R, Mikos AG. Osteoblast function on synthetic biodegradable polymers. J Biomed Mater Res 1994;28:445-1453.
20. Ishaug-Riley SL, Crane GM, Gurlek A, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG. Ectopic bone formation by marrow stromal osteoblast transplantation using poly(DL-lactic-co-glycolic acid) foams implanted into the rat mesentery. J Biomed Mater Res 1997;36:1-8.
21. Kim HD, Smith JG, Valentini RF. Bone morphogenetic protein 2-coated porous poly-L-lactic acid scaffolds: Release kinetics and induction of pluripotent C3H10T1/2 cells. Tiss Engineer 1998;4:35-51.
22. Hollinger JO, Mayer M, Buck D, Zegzula HD, Ron E, Smith J, Lin L, Wozney JM. Poly(alpha-hydroxy acid) carrier for delivering recombinant human bone morphogenetic protein-2 for bone regeneration. J Controlled Rel 1996;39:287-304.
23. Burgess EA, Hollinger JO. Options for engineering bone. In: Patrick CW, Mikos AG, McIntire LV, editors. Frontiers in tissue engineering. New York: Elsevier; to appear.
24. Koutsilieris M, Sourlla A, Pelletier G, Doillo CJ. Three-dimensional type I collagen get system for the study of osteoblastic metastases produced by metastatic prostate cancer. J Bone Min Res 1994;9:1823-1832.
25. Lynch MP, Stein JL, Stein G, Lian JB. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial cell growth, adhesion, and extracellular matrix expression. Exp Cell Res 1995;216:35-45.
26. Helm GA, Sheehan JM, Sheehan JP, Jane J, DiPierro C, Simmons N, Sweeney TM. Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion. J Neurosurg 1997;86:93-100.
27. Hollinger JO, Schmitt JM, Buck DC, Shannon R, Joh SP, Zegzula HD, Wozney JM. Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. J Applied Biomed Mater Res 1998;43:356-364.
28. Marden L, Quigley N, Reddi AH, Hollinger JO. Temporal changes during bone formation in the calvarium induced by osteogenin. Calcif Tissue Int 1993;53:262-268.
29. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whittiers MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: molecular clones and activities. Science 1988;242: 1528-1534.
30. Wang E, Rosen V, Cordes P, Hewick RM, Kriz MJ, Luxenberg DP, Sibley BS, Wozney JM. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 1988;85:9484-9488.
31. Mikos AG, Lyman MD, Freed LE, Langer R. Wetting of poly(L-lactic acid) and poly (DL-lactic-co-glycolic acid) foams for tissue culture. Biomaterials 1994;15:55-58.
32. Hollinger JO, Buck D, Schmitz J. Quantitative light microscopy. A powerful tool to assess bone. In: Hollinger JO, Seyfer A, editors. Bone repair and regeneration. Philadelphia: WB Saunders; 1994. p 463-475.
33. Marden LJ, Hollinger JO, Chaudhari A, Turek T, Schaub R, Ron E. Recombinant bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomies defects in rat. J Biomed Mater Res 1994;28:1127-1138.
34. Lieberman JR, Le LQ, Wu L, Finerman GAM, Berk A, Witte ON, Stevenson S. Regional gene therapy with a BMP-2 producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res 1998;16:330-339.
35. Bruder SP, Kraus KH, Goldberg VM, Kadiyala S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg 1998;80-A:985-996.
36. Hollinger JO. Factors for osseous repair and delivery: Part II. J Craniofac Surg 1993;4:135-141.
37. Shirota T, Ohno K, Suzuki K, Michi K. The effect of aging on the healing of hydroxylapatite implants. J Oral Maxillofac Surg 1993;51:51-56.
38. Caplan AI. The mesengenic process. Clin Plastic Surg 1994;21:29-435.
39. Quarto R, Thomas R, Liang T. Bone progenitor cell deficits and age-associated decline in bone repair capacity. Calcif Tissue Int 1995;56:123-129.
40. Fleet J, Cashman K, Cox K, Rosen V. The effects of aging on the bone inductive activity of recombinant human bone morphogenetic protein-2. Endocrinol 1996;137:4605-4610.
41. Caplan AI, Bruder SP. Cell and molecular engineering of bone regeneration. In: Lanza RP, Langer R, Chick WL, editors. Principles of tissue engineering. Austin: RG Landes Co; San Diego: Academic Press; 1997. p 603-618.
42. Fang J, Zhu Y, Smiley E, Bonadio J, Rouleau J, Goldstein S, McCauley L, Davidson B, Roessler B. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 1996;93:5753-5758.
43. Allay JA, Dennis JE, Haynesworth SE, Majumdar MK, Clapp DW, Shultz LD, Caplan AI, Gerson SL. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Human Gene Ther 1997;8:1417-1427.
44. Takagi K, Urist MR. The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann Surg 1982;196:100-109.
45. Schmitz JP, Hollinger JO. The critical-sized defect as an experimental model for craniomandibulofacial nonunion. Clin Orthop Rel Res 1986;205:299-308.